Related Experiment Video
Updated: Aug 14, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity
Eva Miranda Marwali1,2, Aria Kekalih3, Saptadi Yuliarto4
1Department of Pediatric Cardiac Intensive Care, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia eva.marwali@pjnhk.go.id.
Insights
Children in low-income to middle-income countries (LMICs) faced higher COVID-19 mortality rates compared to high-income countries (HICs). Disparities in treatment access and higher complication rates contributed to this increased risk in LMICs.
Area of Science:
- Global Health
- Infectious Diseases
- Paediatric Medicine
Background:
- The COVID-19 pandemic disproportionately affected paediatric populations globally.
- Significant variations in clinical outcomes were observed between high-income countries (HICs) and low-income to middle-income countries (LMICs).
Purpose of the Study:
- To investigate differences in paediatric clinical outcomes during the COVID-19 pandemic.
- To identify factors contributing to the disparity in outcomes between HICs and LMICs.
Main Methods:
- Utilized the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 database.
- Included children under 19 with suspected or confirmed COVID-19 admitted to hospital between January 2020 and April 2021.
- Performed univariate and multivariable analyses to assess mortality risk factors by country income group.
Main Results:
- Overall in-hospital mortality was 3.3%, higher in LMICs (4.0%) than HICs (1.7%).
- LMICs showed higher mortality rates among mechanically ventilated children (43.6% vs 7.2% in HICs).
- Pre-existing comorbidities (TB, HIV) and complications (ARDS, myocarditis) were more prevalent in LMICs, with LMIC status independently associated with increased mortality risk (aHR 4.73).
Conclusions:
- Paediatric mortality and morbidity from COVID-19 were significantly higher in LMICs compared to HICs.
- Disparities are likely due to differences in patient demographics, disease complications, and access to essential medical interventions and treatments.
Background:
The impact of the COVID-19 pandemic on paediatric populations varied between high-income countries (HICs) versus low-income to middle-income countries (LMICs). We sought to investigate differences in paediatric clinical outcomes and identify factors contributing to disparity between countries.
Methods:
The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 database was queried to include children under 19 years of age admitted to hospital from January 2020 to April 2021 with suspected or confirmed COVID-19 diagnosis. Univariate and multivariable analysis of contributing factors for mortality were assessed by country group (HICs vs LMICs) as defined by the World Bank criteria.
Results:
A total of 12 860 children (3819 from 21 HICs and 9041 from 15 LMICs) participated in this study. Of these, 8961 were laboratory-confirmed and 3899 suspected COVID-19 cases. About 52% of LMICs children were black, and more than 40% were infants and adolescent. Overall in-hospital mortality rate (95% CI) was 3.3% [=(3.0% to 3.6%), higher in LMICs than HICs (4.0% (3.6% to 4.4%) and 1.7% (1.3% to 2.1%), respectively). There were significant differences between country income groups in intervention profile, with higher use of antibiotics, antivirals, corticosteroids, prone positioning, high flow nasal cannula, non-invasive and invasive mechanical ventilation in HICs. Out of the 439 mechanically ventilated children, mortality occurred in 106 (24.1%) subjects, which was higher in LMICs than HICs (89 (43.6%) vs 17 (7.2%) respectively). Pre-existing infectious comorbidities (tuberculosis and HIV) and some complications (bacterial pneumonia, acute respiratory distress syndrome and myocarditis) were significantly higher in LMICs compared with HICs. On multivariable analysis, LMIC as country income group was associated with increased risk of mortality (adjusted HR 4.73 (3.16 to 7.10)).
Conclusion:
Mortality and morbidities were higher in LMICs than HICs, and it may be attributable to differences in patient demographics, complications and access to supportive and treatment modalities.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15:00Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Bias in Epidemiological Studies
Hazard Ratio
For example, in a clinical trial...
Pareto Chart
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
Pneumonia III: Complications and Assessment
Relative Risk